Peptides play roles in many critical biological functions; thus, it is crucial to decipher regulation of peptide expression and signaling. Bioactive peptides are frequently present in precursors that contain multiple structurally related gene products and homologs of neuropeptides often exist in gastrointestinal tissue. Establishing the distribution of physiologically relevant messengers provides insight into regulation of gene expression and peptide activity.
One family of peptides has a common C-terminal FMRFamide but distinct N-terminal extension. It is thought that the C-terminus is essential for binding, while the unique residues of a peptide confer differences in activity (Raffa, 1988) . FMRFamide, isolated as a cardioexcitatory peptide (Greenberg and Price, 1977) , has been shown to elicit a wide variety of responses (Weiss et al., 1984; Robb et al., 1989; Day et al., 1994; Franks et al., 1994; Wang and Orchard, 1995) . In addition, FMRFamide antisera have been used to identify immunoreactive materials and isolate peptides from numerous organisms (Dockray et al., 1983; Yang et al., 1985; Nichols, 1992a,b; Lange et al., 1994; Voronezhskaya and Elekes, 1996; Witten and Truman, 1996; Armstrong et al., 1997) . The conservation of structure, function, spatial and temporal distribution, and abundance of FMRFamide peptides suggests that they play important roles in animal physiology.
Typically, organisms have more than one gene encoding multiple FMRFamide peptides (Nambu et al., 1988; Nichols et al., 1988; Marks et al., 1997) . There is evidence for alternative splicing to produce different FMRFamide transcripts and products (Saunders et al., 1992; Bright et al., 1993; Santama et al., 1995; Price et al., 1997) , and differential posttranslational processing of FMRFamide polypeptide precursors results in cell-specific expression patterns (Santama et al., 1993; Nichols et al., 1995a,b; Santama et al., 1997) . The complexity of processing that FMRFamide precursors undergo provides an animal with a diverse array of gene products to affect a variety of physiological parameters.
We are studying the expression and processing of FMRFamide-containing gene products in Drosophila melanogaster (Nichols et al., 1988 (Nichols et al., , 1995a Nichols, 1992a Nichols, ,b, 1997 McCormick and Nichols, 1993; Nichols and Lim, 1996) . Three Drosophila genes, dromyosuppressin (Dms) (Nichols, 1992a) , drosulfakinin (Dsk) (Nichols et al., 1988) , and FMRFamide (Nambu et al., 1988; Schneider and Taghert, 1988) , encode numerous FMRFamide peptides. We have isolated DPKQDFMRFamide, SDNFMRFamide, and TPAEDFMRFamide (Nichols, 1992a,b) from the Drosophila FMRFamide gene.
Antisera to FMRFamide have been used to identify peptides in the Drosophila central nervous system (White et al., 1986; Chin et al., 1991; O'Brien et al., 1991; Schneider et al., 1991) . While informative, these data are difficult to interpret because FMRFamide antisera do not distinguish among the numerous structurally related peptides. In addition, antisera to the FMRFamide precursor do not provide information on the distribution of individual FMRFamide peptides processed from the gene (Schneider et al., 1993) .
Here, we present TPAEDFMRFamide expression. TPAEDFMRFamide immunoreactivity is present in the central nervous system and midgut at all stages of development. Although TPAEDFMRFamide-immunoreactive material is present in cells stained by FMRFamide antisera, it is not colocalized with DPKQDFMRFamide (Nichols et al., 1995a) or SDNFMRFamide (Nichols et al., 1995b) . In addition, the distribution of TPAEDFMRFamide is a subset of that described for the FMRFamide precursor (Schneider et al., 1993) . These data support the conclusion that the Drosophila FMRFamide polypeptide protein precursor is differentially processed on a cellular level to yield unique distributions of structurally related peptides that may have diverse activities.
MATERIALS AND METHODS

Antigen Design
To generate antisera that would distinguish among the known Drosophila FMRFamide peptides and determine the expression of TPAEDFMRFamide, we raised antisera to TPAED-multiple antigenic peptide (MAP) (Postnett and Tam, 1989; Nichols et al., 1997) . The five amino acid residues of the antigen represent the unique N-terminal extension of TPAEDFMRFamide and do not include the common FMRFamide C-terminal structure, thus avoiding the generation of antisera that would recognize FMRFamide or other Drosophila FMRFamide peptides. We chose to use an MAP antigen to maximize antigenicity and eliminate the need to conjugate the antigen to a carrier protein.
Antisera Generation
Antisera were raised in female New Zealand white rabbits as previously described (Nichols et al., 1995a,b) . All protocols were approved by the University of Michigan Committee on Use and Care of Animals. Sera were assayed as previously described (White et al., 1986; McCormick and Nichols, 1993) .
Antisera Purification
Crude antisera were purified on affinity column resin made by conjugating TPAED-MAP to Affi-gel 10 (BioRad Laboratories) according to the manufacturer's instructions, and equilibrated in 5ϫ phosphate-buffered saline (PBS). The purification protocol was previously described (Nichols et al., 1995a,b; Nichols et al., 1997) .
The specificity of the antisera was determined by designing the antigen to the N-terminal amino acid residues distinguishing TPAEDFMRFamide from FMRFamide and other Drosophila FMRFamide peptides. In addition, the method of purification selected for antisera recognizing TPAEDFMRFamide. Specificity was confirmed by preabsorbing the affinity-purified antisera with 10 Ϫ4 M TPAED-MAP or FMRFamide prior to use in immunolocalization. We refer to the affinity-purified peptide-specific antisera as TPAEDFMRFamide antisera.
Animals
Drosophila melanogaster Oregon R flies were maintained on cornmeal molasses media at 25°C. At each developmental period, neural tissue was dissected from flies of a known age. Animals were collected for dissection based on the number of hours after egg laying for embryos, after hatching for larvae, after becoming white prepupae for pupae, and after eclosing for adults. Central nervous system tissue was dissected from 15-to 16-h embryos, 24-, 48-, 72-, and 96-h larvae, 24-, 48-, 72-, and 90-h pupae, and 3-and 7-day adults. Gastrointestinal tissue was dissected from wandering stage third-instar larvae, pupae, and 7-day adults. No difference in staining was observed between female and male flies.
Immunolocalization
Immunolocalization was performed as previously described (White et al., 1986; McCormick and Nichols, 1993; Nichols et al., 1995a,b) . Briefly, tissue was dissected in Ca 2ϩ -free Ringer's solution (130 mM NaCl, 4.7 mM KCl, 1.8 mM MgCl 2 , 0.74 mM Na 2 HPO 4 , pH 7) and fixed in 4% paraformaldehyde for 4 -6 h at 4°C. After a thorough wash in PTN [0.1 mM NaPO 4 , 0.3% Triton X-100, 0.1% NaAzide, 0.1% bovine serum albumin (BSA)], the tissue was incubated in primary antisera overnight at 4°C with a slow rotatory motion, rinsed in PTN, and then placed in goat anti-rabbit Cy3-conjugated secondary antisera (Jackson ImmunoResearch Laboratories) for 4 -6 h at 4°C. After extensive washing in PTN, the tissue was rinsed in 4 mM NaCarbonate, pH 9, before being mounted in 80% glycerol containing 5% propyl gallate under a glass coverslip. Double-label immunolocalization was performed as previously described (Nichols et al., 1995a,b) . Rabbit antiFMRFamide (Peninsula Laboratories) was detected by fluorescein isothiocyanate (FITC)-labeled goat anti-rabbit second antibody (Sigma Chemical Corp.).
Data Collection and Analysis
Data were collected on a BioRad 600 Kr-Ar laser confocal attached to a Nikon inverted microscope using K1 and K2 filters and a ϫ20 or ϫ40 objective. Optical sections or z series were collected using the CoMos program. Adobe photoshop software, version 3.0, was used to process the data, and images were printed with a Kodak XLS8600 printer.
RESULTS
The terminology used to identify the cells stained by antisera is consistent with previous publications (White et al., 1986; Schneider et al., 1993) . Immunoreactivity was observed bilaterally symmetric to the midline; thus, reference to one cell indicates the presence of a pair of cells positioned bilaterally symmetric to one another. Signal intensity was strong and consistent, and eight or more preparations were analyzed for each experiment.
TPAEDFMRFamide immunoreactivity in embryonic neural tissue is shown in Figure 1 . Staining was present in the nerve cord or ventral ganglion, a fused ganglion composed of three thoracic ganglia and eight abdominal ganglia. The antisera stained 11 cells near the midline of the embryonic ventral ganglion positioned anteriorly to posteriorly along the length of the ganglion in a row or chainlike formation. There was one cell in each of the three thoracic ganglia and a cell per abdominal ganglion, thus accounting for the presence of 11 cells. There were two other immunoreactive cells positioned lateral relative to the chain. These cells, one in the second and one in the third thoracic ganglion, were located ventral relative to the row of cells in the thoracic and abdominal ganglia. An immunoreactive process extended from each stained thoracic and abdominal cell to the midline, where it turned and projected into the subesophageal ganglion. In addition to extending into the subesophageal ganglion, these immunoreactive fibers extended contralaterally across the ventral ganglion midline to form a series of commissure-like connectives or boxes.
The TPAEDFMRFamide antisera staining pattern observed in the first-instar larval central nervous system resembled that present in the embryonic ventral ganglion (Fig. 2) . One noticeable difference between the staining in the embryo and the larva was that the processes along the midline of the ventral ganglion extended further into the brain and began to encircle the esophageal opening. In addition, the boxes made by the processes projecting from the ventral ganglion cells were more defined, forming what resembled a ladder along the length of the nerve cord midline. In third-instar larval neural tissue, the TPAEDFMRFamide-immunoreactive fibers that projected from the ventral ganglion cells completely surrounded the esophageal opening (Fig. 3) . The cells in the nerve cord were intensely stained and there was an additional cell in the first thoracic ganglion that expressed TPAEDFMRFamide. With the staining of an additional cell in the first thoracic ganglion, each of the three thoracic ganglia contained two immunoreactive cells. Several cells in the subesophageal ganglion and brain lobes were detected with antisera although less intensely compared to the ventral ganglion cells. No processes appeared to extend from these subesophageal ganglion and brain lobe cells.
TPAEDFMRFamide-immunoreactive material was also expressed in the 24-h pupal central nervous system (Fig. 4) . The cells stained by antisera in the pupal thoracic ganglion appeared to shift in position as a result, most likely, of morphological changes; however, the overall pattern and number of these cells remained constant. Also, at this time in development, the immunoreactive fibers that projected from the ventral ganglion cells to encircle the esophageal opening branched laterally projecting into the brain (Fig.  4) . Compared to 24-h pupa, the arborization of these projections observed in 72-h pupa was increased with TPAEDFMRFamide-immunoreactive fibers extending through the brain into the optic lobes (Fig. 5) . While faint signal was visible in cells near the esophagus in 72-h pupa, the signal intensity in the ventral ganglion cells and processes remained unchanged.
In adult neural tissue, the number of immunoreactive cells present in the nerve cord decreased by one (Fig. 6) . The thoracic and abdominal ganglia of the adult ventral ganglion contained 13 immunoreactive cells, with one thoracic ganglion cell no longer expressing TPAEDFMRFamide. There remained, however, one immunoreactive cell in the first thoracic ganglion, two cells in the second thoracic ganglion, two cells in the third thoracic ganglion, and one cell per abdominal ganglion that stained with antisera as seen in earlier stages of development. The processes from these cells maintained their signal intensity and contributed to the increased arborization in the ventral ganglion. The immunoreactive projections that origi- Figure 2 TPAEDFMRFamide-immunoreactive material in first-instar larval neural tissue. TPAEDFMRFamide immunoreactivity continues to be expressed in cells in the nerve cord and the processes extending from them. The number of cells expressing TPAEDFMRFamide is consistent from embryo to first-instar larva: one cell in the first thoracic ganglion, two in the second and third ganglia, and one per abdominal ganglia. However, the processes projecting from these cells begin to encircle to the esophageal opening (arrow) in the first-instar neural tissue more completely than seen in the embryo. Bar ϭ 50 m.
nated from the nerve cord cells and encircled the esophageal opening were still present. There was an extensive increase in the complexity of the arborization of the immunoreactive fibers throughout the brain and the optic lobes. In addition, there was one cell in the adult lateral protocerebrum that stained with TPAEDFMRFamide antisera.
We observed TPAEDFMRFamide immunoreactivity in 12 cells in the larval anterior midgut (Fig. 7) . No immunoreactive processes were associated with these cells. The signal intensity was moderate compared to the signal present in the ventral ganglion cells. Similarly, several cells in the pupal gut (data not shown) and in the adult anterior midgut also contained TPAEDFMRFamide-immunoreactive material (Fig.  8) . No TPAEDFMRFamide immunoreactivity was observed in any other region of the gastrointestinal tract at any developmental period examined. Double-label immunolocalization using TPAEDFMRFamide-specific antisera and FMRFamide antisera in the same tissue demonstrated that the TPAEDFMRFamide-immunoreactive ventral ganglion cells were a subset of cells containing FMRFamide-like material (Fig. 9) . The same double-label immunolocalization protocol showed that the midgut cells stained by TPAEDFMRFamide antisera were a subset of cells containing FMRFamide immunoreactivity (Fig. 9) .
DISCUSSION
Regulation of neuropeptide signaling is critical to physiology; hence, several modulatory mechanisms exist. One mode of regulation is at the posttranslational level with cell-specific proteolytic processing enzymes cleaving a polypeptide protein precursor to produce neuropeptides in unique expression patterns (Curry et al., 1991; LeBlanc et al., 1991; Brand et al., 1993; Mineo et al., 1995) . Elucidating regulatory mechanisms involved in peptide expression is essential for understanding neurotransmission. The study of an abundant, diverse family of neuropeptides provides physiologically important information relevant to processing, structure-activity relationship, and function.
Three D. melanogaster genes, Dms, Dsk, and FM- Figure 4 TPAEDFMRFamide-immunoreactive material in 24-h pupal neural tissue. TPAEDFMRFamide immunoreactivity continues to be expressed during metamorphosis. The distribution of the peptide in early pupal central nervous system is similar to that of third-instar larval neural tissue In the pupal central nervous system, however, the processes that extend from the ventral ganglion cells around the esophageal opening begin to arborize laterally into the brain lobes (arrow). Bar ϭ 50 m. RFamide, are known to encode several structurally related FMRFamide peptides (Nambu et al., 1988; Nichols et al., 1988; Taghert, 1988, McCormick et al., 1993) . We have reported the isolation and structure analysis of three Drosophila FMRFamide peptides, DPKQDFMRFamide, SDNFMRFamide, and TPAEDFMRFamide (Nichols, 1992a,b) . We raised antisera specific to DPKQDFMRFamide and SDNFMRFamide and determined their spatial and temporal distribution (Nichols et al., 1995a,b) . The expression of TPAEDFMRFamide has not been described. To elucidate the distribution of TPAEDFMRFamide, we raised antisera to an antigen representing the unique N-terminal extension of the peptide and performed whole-mount immunolocalization on both neural and gastrointestinal tissue. A prominent feature of TPAEDFMRFamide expression at all stages of development was the staining of nerve cord cells and the immunoreactive fibers that extended from these cells and projected into the subesophageal ganglion (Figs. 1-6 ). The number and position of cells stained were constant and the signal was strong, suggesting that TPAEDFMRFamide plays an important role(s) throughout the life of the animal. The quantity and complexity of the immunoreactive ventral ganglion cells and associated projections implied that there may be several sources of input into the release of TPAEDFMRFamide and numerous sites of TPAEDFMRFamide action.
The appearance of processes around the esophageal opening during development implies that TPAEDFMRFamide has a role(s) relative to the function of the esophagus (Figs. 1-6 ). The origin of fibers suggests that there are multiple sources from which information can be derived to affect release at this site(s). Our method of dissecting neural tissue from surrounding and attached tissue does not allow us to track the TPAEDFMRFamide innervation to its full extent. However, we know from our analysis of gastrointestinal tissue that TPAEDFMRFamide-containing fibers do not terminate directly on the foregut. This does not preclude that the peptide is released from these nerve endings to act on other neurons that directly innervate the esophagus and/or gut.
Fibers extended into the subesophageal ganglion and brain, and projections from the thoracic and ab- Figure 6 TPAEDFMRFamide-immunoreactive material in neural tissue from 3-day adult. TPAEDFMRFamide continues to be expressed in cells and processes in the adult ventral ganglion and brain. The brain and optic lobe immunoreactive processes have significantly increased in number and complexity. In addition, a lateral protocerebrum cell is stained intensely with TPAEDFMRFamide antisera (arrow). Bar ϭ 50 m. dominal cells crossed the midline to form commissures to give the fasiculating neurites a ladderlike appearance along the length of the nerve cord that is present throughout development (Figs. 1-6 ). The continued presence of these projections stained with TPAEDFMRFamide antisera implies that this region may constitute an important peptidergic release site(s).
The immunoreactive processes at the midline of the ventral ganglion (Figs. 1-6 ) coincided with a neuronal sheath that has been described as one of two neurohemal release sites in Drosophila and the blowfly, Calliphora vomitoria (Raabe, 1989; Lundquist and Nässel, 1990; Nässel et al., 1994) . It has been reported that subesophageal neurons in Calliphora send processes to this neurohemal region and release serotonin into the circulation at this site (Nässel and Elekes, 1985; Trimmer, 1985) . This is notable because of the precedence for the interaction of FMRFamide peptides with serotonin (Brownlee et al., 1995; Wurden and Homberg, 1995) . Furthermore, consistent with this expression of TPAEDFMRFamide, FMRFamide-like materials are reported to have neurohormonal functions (Myers and Evans, 1985; Carroll et al., 1986; Jagdale and Gordon, 1994; Schoofs et al., 1997) . In addition, FMRFamide-immunoreactive material has been observed to be released from peptidergic fibers of the Calliphora dorsal sheath (Nässel et al., 1994) .
TPAEDFMRFamide immunoreactivity in the optic lobes (Figs. 4 -6 ) implies that the peptide may play a role in phototransduction or associated neural functions. TPAEDFMRFamide staining is present in the lobula, an area in which there are a number of neurons that sense motion and direction relaying messages to the appropriate neural centers (Strausfeld, 1976 (Strausfeld, , 1984 Mobbs, 1985) . Thus, TPAEDFMRFamide may be involved in communicating some aspect of motion.
The TPAEDFMRFamide-immunoreactive adult lateral protocerebral cell (Fig. 6) is located in the region of the antennal lobe where sensory information detected by the antennae is processed (Mobbs, 1985) . The appearance of signal in this cell in the adult, the stage when the antennae are functional, may indicate that TPAEDFMRFamide is involved in sensory stimuli signaling. This is in agreement with what is found in other organisms, where FMRFamide peptides act to relay sensory information in neural tissue as indicated by immunolocalization and electrophysiological data (Umino and Dowling, 1991; Cowden et al., 1993; Wikgren and Fagerholm, 1993; Xu et al., 1994) .
The cells in the anterior midgut containing TPAEDFMRFamide immunoreactivity (Figs. 7 and 8) are present in the region of the gastrointestinal tract where digestion and absorption occur (Demerec, 1950) . Peptidergic cells are present in this region of the midgut in Drosophila, Calliphora, and other insects (Zitnan et al., 1993 , Nässel et al., 1994 . Gut endocrine cells may function to perceive nutrient content and/or tension of the muscle wall (Fujita et al., 1988) . The action of these cells is probably local and may affect gut movement, production of digestive enzymes, circulation in the digestive tissue, and/or epithelial shedding. The presence of TPAEDFMRFamide in the anterior midgut suggests that it may be involved in these gastrointestinal processes.
Since our antisera recognized the N-terminal amino acid residues of TPAEDFMRFamide and not the C-terminal FMRFamide, we performed double immunolabeling experiments to confirm that TPAEDFMRFamide antisera staining was coincident with FMRFamide-immunoreactive material. Our doublelabel immunolocalization with TPAEDFMRFamide antisera and FMRFamide antisera showed that the TPAEDFMRFamide staining was a subset of FMRFamide immunoreactivity in both neural and gut tissues (Fig. 9) . In neural tissue (Fig. 9, upper panel) , FMRFamide-stained cells were labeled with secondary antisera conjugated to FITC (green), while the TPAEDFMRFamide-containing cells were labeled with a secondary antisera conjugated to Cy3 (red). Overlap of the green and red fluorescence signals produced yellow and demonstrated that TPAEDFMRFamide was expressed in a subset of cells also stained with FMRFamide antisera. In the gastrointestinal tract (Fig. 9, lower panel) , TPAEDFMRFamide was present in cells also stained with FMRFamide antisera. Cy3-conjugated secondary antisera (red) recognized TPAEDFMRFamide antisera and FITC (green)-labeled secondary antisera recognized FMRFamide antisera. Yellow fluorescence resulted when TPAEDFMRFamide antisera bound antigen in a subset of cells stained with FMRFamide antisera. Thus, it is likely that our peptide-specific TPAEDFMRFamide antisera recognized TPAEDFMRFamide and not a substance with a structurally similar N-terminus. This argument is also supported by the fact that the TPAEDFMRFamide expression pattern is contained within the distribution of the Drosophila FMRFamide transcript and precursor Schneider et al., 1991 Schneider et al., , 1993 .
Together with previous studies (Nichols et al., 1995a,b) , these immunolocalization data indicate that the Drosophila FMRFamide gene products DPKQDFMRFamide, SDNFMRFamide, and TPAEDFMRFamide have unique spatial and temporal distributions (Fig. 10) . DPKQDFMRFamide antisera stain cells in each of the three thoracic ganglia, one cell in the subesophageal ganglion, and several cells in the superior protocerebrum (Nichols et al., 1995a) . The thoracic ganglia cells stained by DPKQDFMRFamide antisera are more dorsal than those stained by TPAEDFMRFamide (Nichols et al., 1995a) . SDNFMRFamide immunoreactivity is present in several cells of the subesophageal ganglion, but is not present in the cells of the nerve cord (Nichols et al., 1995b) . The patterns of expression of both DPKQDFMRFamide and SDNFMRFamide are subsets of FMRFamide antisera staining and are present in cells containing the FMRFamide polyprotein precursor (Nichols et al., 1995a,b) .
TPAEDFMRFamide-immunoreactive material is expressed in the central nervous system and gastrointestinal tract in all stages of development, suggesting that the peptide has important roles in physiology. Double-immunolabeling data indicate that TPAEDFMRFamide antisera staining is a subset of FMRFamide immunoreactivity (Fig. 9) and TPAEDFMRFamide appears to be present in cells containing the FMRFamide precursor (Schneider et al., 1993) . In addition, TPAEDFMRFamide-immunoreactive material does not coexist with DPKQDFMRFamide and SDNFMRFamide ( Fig. 10) (Nichols et al., 1995a,b) . These data support the conclusion that differential posttranslational processing of the Drosophila FMRFamide polypeptide precursor to produce unique cellular expression patterns is a means by which to regulate the distribution of structurally related peptides that may have diverse and different activities. 
